These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2999615)

  • 1. Effect of forskolin on platelet deaggregation and cyclic AMP generation.
    Kariya T; Morito F; Sakai T; Takahata K; Yamanaka M
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct; 331(1):119-21. PubMed ID: 2999615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets.
    Williams KA; Murphy W; Haslam RJ
    Biochem J; 1987 May; 243(3):667-78. PubMed ID: 2444206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of platelet aggregation by 6-keto-PGE1; lack of an effect on cyclic GMP levels.
    Pontecorvo EG; Myers CB; Lippton HL; Kadowitz PJ
    Prostaglandins Med; 1981 May; 6(5):473-83. PubMed ID: 6267636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of forskolin and organic nitrate on aggregation and intracellular cyclic nucleotide content in human platelets.
    Anfossi G; Massucco P; Mularoni E; Cavalot F; Mattiello L; Trovati M
    Gen Pharmacol; 1994 Oct; 25(6):1093-100. PubMed ID: 7875530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ticlopidine facilitates the deaggregation of human platelets aggregated by thrombin.
    Cattaneo M; Akkawat B; Kinlough-Rathbone RL; Packham MA; Cimminiello C; Mannucci PM
    Thromb Haemost; 1994 Jan; 71(1):91-4. PubMed ID: 8165651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostacyclin potentiates 13-azaprostanoic acid-induced platelet deaggregation.
    Parise LV; Venton DL; Le Breton GC
    Thromb Res; 1982 Dec; 28(6):721-30. PubMed ID: 6301090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Released adenosine diphosphate stabilizes thrombin-induced human platelet aggregates.
    Cattaneo M; Canciani MT; Lecchi A; Kinlough-Rathbone RL; Packham MA; Mannucci PM; Mustard JF
    Blood; 1990 Mar; 75(5):1081-6. PubMed ID: 2137716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of prostaglandins with adenosine diphosphate induced increase in cytosolic free calcium in human platelets.
    Ohman KP; Yun JC; Keiser HR
    Scand J Clin Lab Invest; 1992 Oct; 52(6):483-90. PubMed ID: 1329185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function.
    Fisher CA; Kappa JR; Sinha AK; Cottrell ED; Reiser HJ; Addonizio VP
    J Lab Clin Med; 1987 Feb; 109(2):184-90. PubMed ID: 2433373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forskolin and prostacyclin inhibit fluoride induced platelet activation and protein kinase C dependent responses.
    Doni MG; Deana R; Bertoncello S; Zoccarato F; Alexandre A
    Biochem Biophys Res Commun; 1988 Nov; 156(3):1316-23. PubMed ID: 2847730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forskolin alters sensitivity of the cAMP-generating system to stimulatory as well as to inhibitory agonists. A study with intact human platelets and guinea pig myometrium.
    Mokhtari A; Do Khac L; Harbon S
    Eur J Biochem; 1988 Sep; 176(1):131-7. PubMed ID: 2843365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic AMP-dependent phosphorylation of glycoprotein Ib inhibits collagen-induced polymerization of actin in platelets.
    Fox JE; Berndt MC
    J Biol Chem; 1989 Jun; 264(16):9520-6. PubMed ID: 2542312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the cAMP-elevating agents cilostamide, cilostazol and forskolin on the phosphorylation of Akt and GSK-3beta in platelets.
    Hayashi H; Sudo T
    Thromb Haemost; 2009 Aug; 102(2):327-35. PubMed ID: 19652884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental Differences in Platelet Inhibition Response to Prostaglandin E1.
    Palma-Barqueros V; Torregrosa JM; Caparrós-Pérez E; Mota-Pérez N; Bohdan N; Llanos MDC; Begonja AJ; Sola-Visner M; Vicente V; Teruel-Montoya R; Rivera J; Ferrer-Marín F
    Neonatology; 2020; 117(1):15-23. PubMed ID: 31786577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH; Haslam RJ
    Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E1 potentiates the effects of P2Y12 blockade on ADP-mediated platelet aggregation in vitro: Insights using short thromboelastography.
    Khanna V; Armstrong PC; Warner TD; Curzen N
    Platelets; 2015; 26(7):689-92. PubMed ID: 25734957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effects of butyrate on platelet responses to arachidonate, A23187, PGE1, and forskolin.
    Tandon NN; Tralka TS; Jamieson GA
    Blood; 1986 Feb; 67(2):366-72. PubMed ID: 3080038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin.
    Beretz A; Stierle A; Anton R; Cazenave JP
    Biochem Pharmacol; 1982 Nov; 31(22):3597-600. PubMed ID: 6295405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of SK&F 94120, an inhibitor of cyclic nucleotide phosphodiesterase type III, on human platelets.
    Simpson AW; Reeves ML; Rink TJ
    Biochem Pharmacol; 1988 Jun; 37(12):2315-20. PubMed ID: 2455518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of aggregation and stimulation of cyclic AMP generation in intact human platelets by the diterpene forskolin.
    Siegl AM; Daly JW; Smith JB
    Mol Pharmacol; 1982 May; 21(3):680-7. PubMed ID: 6287202
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.